Shanghai, China

Jialin Shang

This inventor holds 1 USPTO granted patent. Top assignee: Nutshell Biotech (Shanghai) Co., Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jialin Shang. Retrieved from https://idiyas.com/inventor/jialin-shang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jialin Shang: Innovator in Pharmaceutical Development

Introduction

Jialin Shang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on small-molecule activators.

Latest Patents

Jialin Shang holds 1 patent for a compound used as a SIRT6 small-molecule allosteric activator and its pharmaceutical composition. This invention discloses an SIRT6 small-molecule allosteric activator that contains a derivative or a pharmacologically acceptable salt as the active ingredient. The activator designed and synthesized in this invention demonstrates high efficacy and low toxicity. It significantly activates SIRT6 activity during in vitro experiments and holds great importance in the development of pharmaceuticals for relevant diseases.

Career Highlights

Jialin Shang is currently associated with Nutshell Biotech (Shanghai) Co., Ltd. His work at this company focuses on advancing pharmaceutical innovations that can lead to better treatment options for various diseases.

Collaborations

Some of his coworkers include Jian Zhang and Yinyi Chen, who contribute to the collaborative efforts in research and development within the company.

Conclusion

Jialin Shang's innovative work in the pharmaceutical sector, particularly with his SIRT6 small-molecule allosteric activator, showcases his commitment to advancing medical science. His contributions are poised to make a significant impact on the treatment of relevant diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…